GE HealthCare Technologies Inc.

NASDAQ:GEHC

Medical - Healthcare Information Services

Healthcare
$83.66 +0.74%

+$0.45 today

Market cap
$37.83B
Beta
0.86
P/E (TTM)
18.7
EPS (TTM)
$3.30
Dividend yield
0.23%
52W Low $58.75High $89.77

Volume 3.65M

Average 4.84M

GEHC Research & Development

Spending on developing new products, technologies, and improvements to existing offerings.

GE HealthCare Technologies Inc.NASDAQ: GEHC

Research & Development · Q2 FY2026 · quarter ended Jun 2026

Research & development growth accelerates

Q2 FY2026 research & development of $323M rose 7.0% year over year, ahead of the +1.2% change in trailing-twelve-month research & development. Sequentially, it fell 6.4% from the prior quarter. Over 3 fiscal years it compounded at +7.1% a year.

Context

  • Research & development amounted to 6.1% of revenue in FY2025, down 0.6 pp from a year earlier.
  • Research & development increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly growth of +7.0% holds above the trailing-twelve-month pace of +1.2%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
$323M-6.4% QoQ
Last fiscal yearDec 2025
$1.26B-3.9% YoY
LTMJun 2026
$1.32B+1.2% YoY
Research & Development past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+7.0%——
1 year-3.9%——
3-year CAGR+7.1%——
5-year CAGR——
10-year CAGR——

Research & Development history

USD · from the income statement

Latest · FY2025
1.26B USD
Year-over-year change
-3.9%
4-year CAGR
+11.5%

Research & Development vs competitors

How GEHC compares with its peers on the latest reported figures

  • Peers report in different currencies, so research & development is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +1.2% is the 5th highest of 6, against a peer median of +10.1%.
  • Research & development amounts to 6.5% of revenue for GEHC, versus a peer median of 7.8%.
GEHC Competitors
Research & Development for GEHC and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ABTAbbott LaboratoriesLTM Sep 2026$3.28B USD+11.3%+1.2%6.8%
MDTMedtronic plcLTM Jul 2026$2.92B USD+4.9%+2.1%7.8%
BSXBoston Scientific CorporationLTM Jun 2026$2.15B USD+17.3%+15.8%10.3%
PHGKoninklijke Philips N.V.LTM Jun 2026€1.72B EUR-2.6%-6.7%9.7%
SYKStryker CorporationLTM Jun 2026$1.66B USD+10.1%+8.8%6.4%
GEHCGE HealthCare Technologies Inc.LTM Jun 2026$1.32B USD+1.2%+7.1%6.5%
Peer median (excluding GEHC) —+10.1%+2.1%7.8%

Competitors are the stored peer set for GEHC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue17.59B18.34B19.55B19.67B20.63B
Cost of Revenue10.41B11.16B11.63B11.47B12.38B
Gross Profit7.17B7.18B7.92B8.21B8.25B
Gross Margin40.8%39.1%40.5%41.7%40.0%
Research & Development816M1.03B1.21B1.31B1.26B
Selling, General & Admin3.56B3.63B4.28B4.27B4.23B
Operating Expenses4.38B4.66B5.49B5.58B5.49B
Depreciation & Amortization625M633M610M580M578M
EBITDA3.54B3.17B3.51B3.67B3.79B
EBITDA Margin20.1%17.3%18.0%18.6%18.4%
Operating Income2.8B2.52B2.44B2.63B2.76B
Operating Margin15.9%13.8%12.5%13.3%13.4%
Interest Income34M026M00
Interest Expense40M86M542M505M450M
Other Income / Expenses80M(10M)(74M)(44M)6M
Income Before Tax2.88B2.51B2.36B2.58B2.77B
Pre-Tax Margin16.3%13.7%12.1%13.1%13.4%
Income Tax Expense600M563M743M531M614M
Net Income2.25B1.92B1.57B1.99B2.08B
Net Margin12.8%10.4%8.0%10.1%10.1%
EPS (Basic)4.904.223.044.374.56
EPS (Diluted)4.904.223.024.344.55
Weighted Avg Shares454.71M453.93M455M456M456.52M
Weighted Avg Shares (Diluted)454.71M453.93M458M459M460.27M

GE HealthCare Technologies Inc.

NASDAQ:GEHC

Intrinsic Alpha fair value

Locked

Current Price

$83.66

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.